The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Nephrology"
DOI: 10.1159/000484633
Abstract: Background: People with diabetes and kidney disease have a high risk of cardiovascular events and progression of kidney disease. Sodium glucose co-transporter 2 inhibitors lower plasma glucose by reducing the uptake of filtered glucose in… read more here.
Keywords: kidney; diabetes established; credence; canagliflozin renal ... See more keywords